EU expands label for Tandem insulin delivery systems
Tandem Diabetes Care received EU approval to expand the label for its t:slim X2 and Tandem Mobi automated insulin delivery systems, allowing broader use in diabetes management.
Medical device news covering implants, diagnostics, recalls, FDA clearances, and medtech company performance.
Tandem Diabetes Care received EU approval to expand the label for its t:slim X2 and Tandem Mobi automated insulin delivery systems, allowing broader use in diabetes management.